A carregar...

TEAMS: Toxicity- and Efficacy-based Dose Insertion Design with Adaptive Model Selection for Phase I/II Dose-Escalation Trials in Oncology

In many oncology clinical trials it is necessary to insert new candidate doses when the prespecified doses are poorly elicited. Formal statistical designs with dose insertion are lacking. We propose a dose insertion design for phase I/II clinical trials in oncology based on both efficacy and toxicit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stat Biosci
Main Authors: Guo, Wentian, Ni, Yang, Ji, Yuan
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4627719/
https://ncbi.nlm.nih.gov/pubmed/26528377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12561-015-9133-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!